* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *
Full Coverage

Michael R. Merson Joins AspenBio Pharma's Board of Directors

                   
pharmiweb.co.uk
08-Jul-2008
        
Story Timeline:  95 days

Released : Tuesday, July 08, 2008 11:28 AM CASTLE ROCK, CO, July 8 / MARKET WIRE/ -- AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has appointed Michael R. Merson as a new independent member of its board of directors. This appointment brings the total number of company directors to seven, with five serving independently. Merson is a highly seasoned health care executive, having founded and managed several healthcare organizations, from hospitals to health insurers. Since 2004, he has served as chairman of CareFirst Blue Cross/Blue Shield, the 16th largest health insurer in the United States, with annual revenues of approximately $7.0 billion and more than 3.2 million insured individuals. CareFirst is part of the... [read full story]                    

Add Comment
Latest article on this story:

Michael R. Merson Joins AspenBio Pharma's Board of Directors

 genengnews.com 08-Jul-2008
First article on this story:

Michael R. Merson Joins AspenBio Pharma's Board of Directors

 tmcnet.com 08-Jul-2008
Selected publications with coverage of this story:
redorbit.com marketwire.com yahoo.com genengnews.com tmcnet.com pharmiweb.co.uk
RELATED
No documents found.